Paradigm Shifts in Gynecologic Oncology

Paradigm Shifts in Gynecologic OncologyData: 1 – 2 luglio 2021

Luogo: Varese, Ville Ponti

Learning with friends

 

 

 

Vai al sito »

 

CONFERENCE SUMMARY

Over the last years, some scientific publications dramatically impacted the management of gynecological cancers. In this context, we organized an event to share the results of the most significant studies, which somehow represented a paradigm shift in uterine, cervical, and ovarian cancers.

A two-days conference will  give the chance to the attendances to understand the meaning of working in teams, learning from mentors and friends. High-level national and international speakers will share their expertise and will deliver inspiring talks with unique insights. The proposed topics will be presented with reference to evidence-based medicine and in accordance with the most recent national and international guidelines.

Mixed in-person and virtual interactive sessions will give the opportunity to question leading experts and be inspired by best practices from different countries.

The meeting is intended for gynecologic oncologists, medical oncologists, radiation oncologists, pathologists, general gynecologists, nurses, residents and physician other clinicians involved in the care of patients with gynecologic malignancies.

 

 

PROGRAM

Thursday, July 01

15.00 – Registration
15.30 – Opening session – J. Casarin
15.45 – Gynecologic Oncology at “Del Ponte Hospital” of Varese: past present and future perspectives – F. Ghezzi

Session 1. OVARIAN CANCER
Chair: : P. Beretta / A. Ditto / G. Scambia

16:15 – Early detection in ovarian cancer – A. Ahmed
16:45 – Improving the outcome of early ovarian cancer treatment – S. Uccella
17:05 – Radical surgery in ovarian cancer: morbidity and oncological outcomes – G. Aletti
17:25 – Neoadjuvant chemotherapy for advanced stage ovarian cancer: how to select the patients? – L. Tortorella
17:45 – Adjuvant treatment following cytoreductive surgery for advanced stage ovarian cancer: updates and latest evidence – N. Colombo
18:05 – Role of surgery in recurrent ovarian cancer – A. Du Bois
18:25 – Discussion /Q&A/ OVARIAN CANCER – A. Ahmed – G. Aletti – N. Colombo – A. du Bois – L. Tortorella – S. Uccella
18:45 – Daily final remarks

 

Friday, July 02

08.30 – Registration

Session 2. IMPROVEMENT IN GYNECOLOGIC CANCER CARE
Chair: A. Buda / V. Di Donato / F. Odicino

09:00 – Clinical application of molecular biology and cancer genetics in ovarian cancers – T.Grassi
09:25 – Advanced ultrasound evaluation for gynecologic malignancies: the actual impact on the preoperative work-up – D. Sturla
09:50 – Enhanced Recovery After Surgery (ERAS): a multidisciplinary, multi-modal approach to perioperative care in gynecologic oncology – G. Salvo
10:15 – Challenges and barriers to implementation of the ERAS pathway in Italy – F. Ferrari
10:45 – Discussion / Q&A / IMPROVEMENT IN GYNECOLOGIC CANCER CARE – F. Ferrari – T. Grassi – G. Salvo – D. Sturla
11.00 – Coffee break

Session 3. CERVICAL CANCER
Chair: M. Franchi / F. Raspagliesi

11.30 – The Role of Human Papillomavirus Vaccines in Cervical Cancer: Prevention and Treatment – G. Bogani
12.00 – Surgical treatment for apparent early stage cervical cancer: back to the “open” forever? – P. Ramirez
12.20 – Sentinel lymph node for cervical cancer staging – A.Buda
12:40 – Contraindication to NACT and surgery in locally advanced cervical cancer – F. Landoni
13:00 – Discussion /Q&A/ CERVICAL CANCER – G. Bogani – A. Buda – F. Landoni – P. Ramirez
13.30 – Box Lunch
14.30 – Friendship in science and medicine – N. Abu-Rustum – A. Mariani – P. Ramirez

Session 4. ENDOMETRIAL CANCER
Chair: F. Ghezzi / S. Greggi / V. Zanagnolo

15:10 – Minimally invasive surgery in endometrial cancer: the long and winding road to reduce morbidity – S. Cappuccio
15:30 – Lymphadenectomy vs. sentinel lymph node biopsy: surgical and oncological outcomes – A. Papadia
15:50 – The “5Ws”of adjuvant treatment in endometrial cancer: What – When – Where – to Whom and Why? – A. Mariani
16:10 – New perspectives on the management of endometrial cancer – the role of molecular classification – F. Multinu
16:30 – Discussion /Q&A/ ENDOMETRIAL CANCER – S. Cappuccio – A. Mariani – F. Multinu – A. Papadia
17:30 – Final Tests

 

 

SEGRETERIA ORGANIZZATIVA

PSA&CF
Via Giulio Cesare Procaccini 24 – 21100, Varese (VA)
Tel. 0332 1570554
informazioni@psacf.itwww.psacf.it

 

 

Copyright © Theramex 2022

Log in with your credentials

Forgot your details?